Works matching IS 00099236 AND DT 2025 AND VI 117 AND IP 2

Results: 35
    1

    In this Issue.

    Published in:
    Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 2, p. 319, doi. 10.1002/cpt.3519
    Publication type:
    Article
    2
    3

    Building Confidence in Physiologically Based Pharmacokinetic Modeling of CYP3A Induction Mediated by Rifampin: An Industry Perspective.

    Published in:
    Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 2, p. 403, doi. 10.1002/cpt.3477
    By:
    • Reddy, Micaela B.;
    • Cabalu, Tamara D.;
    • de Zwart, Loeckie;
    • Ramsden, Diane;
    • Dowty, Martin E.;
    • Taskar, Kunal S.;
    • Badée, Justine;
    • Bolleddula, Jayaprakasam;
    • Boulu, Laurent;
    • Fu, Qiang;
    • Kotsuma, Masakatsu;
    • Leblanc, Alix F.;
    • Lewis, Gareth;
    • Liang, Guiqing;
    • Parrott, Neil;
    • Pilla Reddy, Venkatesh;
    • Prakash, Chandra;
    • Shah, Kushal;
    • Umehara, Kenichi;
    • Mukherjee, Dwaipayan
    Publication type:
    Article
    4

    A Novel Step‐Up Dosage Regimen for Enhancing the Benefit‐to‐Risk Ratio of Mosunetuzumab in Relapsed or Refractory Follicular Lymphoma.

    Published in:
    Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 2, p. 465, doi. 10.1002/cpt.3445
    By:
    • Li, Chi‐Chung;
    • Bender, Brendan;
    • Wilkins, Justin;
    • Li, Feifei;
    • Turner, David C.;
    • Wang, Bei;
    • Deng, Rong;
    • Vadhavkar, Shweta;
    • Li, Zao;
    • Kwan, Antonia;
    • Huang, Huang;
    • Peng, Kun;
    • Penuel, Elicia;
    • Huw, Ling‐Yuh;
    • Chanu, Pascal;
    • Li, Chunze;
    • Yin, Shen;
    • Wei, Michael C.
    Publication type:
    Article
    5

    Highlighted Articles.

    Published in:
    Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 2, p. 324, doi. 10.1002/cpt.3523
    Publication type:
    Article
    6

    ASCPT News.

    Published in:
    Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 2, p. 326, doi. 10.1002/cpt.3522
    Publication type:
    Article
    7
    8

    French‐Speaking Network of Pharmacogenetics (RNPGx) Recommendations for Clinical Use of Mavacamten.

    Published in:
    Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 2, p. 387, doi. 10.1002/cpt.3502
    By:
    • Lebreton, Louis;
    • Boyer, Jean‐Christophe;
    • Lafay‐Chebassier, Claire;
    • Hennart, Benjamin;
    • Baklouti, Sarah;
    • Cunat, Séverine;
    • Vilquin, Paul;
    • Medard, Yves;
    • Gautier‐Veyret, Elodie;
    • Laffitte‐Redondo, Clara;
    • Verstuyft, Céline;
    • Ait Tayeb, Abd El Kader;
    • Haufroid, Vincent;
    • Wils, Julien;
    • Lamoureux, Fabien;
    • Evrard, Alexandre;
    • Davaze‐Schneider, Julie;
    • Ben‐Sassi, Mouna;
    • Picard, Nicolas;
    • Quaranta, Sylvie
    Publication type:
    Article
    9

    Model‐Informed Drug Development‐Based Approval of Intravenous Secukinumab for the Treatment of Adult Patients with Active Psoriatic Arthritis, Active Ankylosing Spondylitis, and Active Non‐Radiographic Axial Spondyloarthritis.

    Published in:
    Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 2, p. 475, doi. 10.1002/cpt.3464
    By:
    • Pisal, Dipak S.;
    • Li, Yangbing;
    • Golding, Amit;
    • Nair, Raj;
    • Nikolov, Nikolay P.;
    • Madabushi, Rajanikanth;
    • Zhu, Hao;
    • Doddapaneni, Suresh;
    • Sahajwalla, Chandrahas;
    • Bi, Youwei;
    • Chen, Jianmeng
    Publication type:
    Article
    10
    11
    12
    13
    14
    15

    Artificial Intelligence in European Medicines Regulation: From Vision to Action. Harnessing the Capabilities of Artificial Intelligence for the Benefit of Public and Animal Health.

    Published in:
    Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 2, p. 335, doi. 10.1002/cpt.3494
    By:
    • Correia Pinheiro, Luis;
    • Arlett, Peter;
    • Roes, Kit;
    • Musuamba Tshinanu, Flora;
    • Westman, Gabriel;
    • Frias, Zaide;
    • Hamann, Hilmar;
    • Berenguer Jornet, Joaquim;
    • Khan, Iftekhar;
    • Larsen, Jeppe;
    • Broich, Karl;
    • Cooke, Emer
    Publication type:
    Article
    16
    17
    18
    19
    20

    Effects of Cimetidine and Dolutegravir on the Endogenous Drug–Drug Interaction Biomarkers for Organic Cation Transporter 2 and Multidrug and Toxin Extrusion Protein 1 in Healthy Volunteers.

    Published in:
    Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 2, p. 523, doi. 10.1002/cpt.3482
    By:
    • Koishikawa, Tomoki;
    • Fujiwara, Kaku;
    • Taskar, Kunal;
    • Zamek‐Gliszczynski, Maciej J.;
    • Yoshida, Kenta;
    • Chu, Xiaoyan;
    • Hirabayashi, Hideki;
    • Mao, Jialin;
    • Rockich, Kevin;
    • Takashima, Tadayuki;
    • Yamaura, Yoshiyuki;
    • Lai, Yurong;
    • Tomoda, Yukana;
    • Kito, Tomoko;
    • Maeda, Kazuya;
    • Furihata, Kenichi;
    • Sugiyama, Yuichi;
    • Kusuhara, Hiroyuki
    Publication type:
    Article
    21
    22
    23
    24
    25

    Drug–Drug Interaction Between Dihydroartemisinin–Piperaquine and Sulfadoxine‐Pyrimethamine During Malaria Chemoprevention in Pregnant Women.

    Published in:
    Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 2, p. 506, doi. 10.1002/cpt.3471
    By:
    • Mwebaza, Norah;
    • Roh, Michelle E.;
    • Geng, Yourong Z.;
    • Opio, Leonard;
    • Opira, Bishop;
    • Marzan, Florence;
    • Mwima, Moses W.;
    • Ssemukuye, Timothy;
    • Guo, Kevin;
    • Gingrich, David;
    • Fotaki, Nikoletta;
    • Kakuru, Abel;
    • Kizza, Jimmy;
    • Aguti, Miriam;
    • Adrama, Harriet;
    • Kamya, Moses;
    • Dorsey, Grant;
    • Rosenthal, Philip J.;
    • Aweeka, Francesca T.;
    • Huang, Liusheng
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35

    Issue Information.

    Published in:
    Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 2, p. 311, doi. 10.1002/cpt.3318
    Publication type:
    Article